| Adamopoulos C, Ahmed A, Fay R, et al.
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial. [Journal Article, Research Support, Non-U.S. Gov't]
Eur J Heart Fail 2009 Nov; 11(11):1099-105.
Abstract | Full Citation | Find Related Articles | | Sato A, Fukuda S
Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension. [JOURNAL ARTICLE]
J Hum Hypertens 2009 Oct 29.
Abstract | Full Citation | | Mak GJ, Ledwidge MT, Watson CJ, et al.
Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. [Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
J Am Coll Cardiol 2009 Oct 27; 54(18):1674-82.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hlavacova N, Bakos J, Jezova D
Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release. [JOURNAL ARTICLE]
J Psychopharmacol 2009 Oct 13.
Abstract | Full Citation | | Morales E, Huerta A, Gutiérrez E, et al.
The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? [JOURNAL ARTICLE]
Nefrologia 2009 Oct; 29(5):421-429.
Abstract | Full Citation | | Qian WJ, Ding L, Wen AD, et al.
Establishment of HPLC-ESI-MS method for the determination of eplerenone in human plasma and its pharmacokinetics. [Journal Article]
Yao Xue Xue Bao 2009 Jul; 44(7):771-7.
Abstract | Full Citation | Find Related Articles | | Kamari Y, Shimoni N, Koren F, et al.
High-salt diet increases plasma adiponectin levels independent of blood pressure in hypertensive rats: the role of the renin-angiotensin-aldosterone system. [JOURNAL ARTICLE]
J Hypertens 2009 Sep 18.
Abstract | Full Citation | | Li H, Förstermann U
Prevention of atherosclerosis by interference with the vascular nitric oxide system. [Journal Article, Research Support, Non-U.S. Gov't]
Curr Pharm Des 2009; 15(27):3133-45.
Abstract | Full Citation | | Stowasser M
Update in primary aldosteronism. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Endocrinol Metab 2009 Oct; 94(10):3623-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bauersachs J
[Aldosterone antagonists for all patients with heart failure?] [Journal Article]
MMW Fortschr Med 2009 Apr 9; 151(15):33-5.
Full Citation |   |
|
| |
Advertise on this site.
|
